Biocept receives south korean patent for primer-switch platform used to identify rare genetic mutations, including cancer biomarkers

San diego--(business wire)-- #cancer--biocept was awarded a south korean patent for its primer-switch technology, which identifies rare genetic mutations, including cancer biomarkers.

BIOC Ratings Summary

BIOC Quant Ranking